Unfortunately, unexpected problems with the launch of MyCIPO resulted in a complete lack of public access to, and a complete lack of updating of, the Canadian Patent Database from July 17 to around August 1. During this period, database information was not available by any other means. The database is back online, with much more detailed information regarding the status of patents and patent applications. However, users have noticed inconsistencies in search results and inaccuracy of data.
The launch of MyCIPO also resulted in significant delays in processing incoming correspondence, which are ongoing, as well as a complete lack of outgoing correspondence for several weeks, though outgoing correspondence has now resumed. This has resulted in significant, ongoing, delays in issuance of filing certificates and application filing numbers, for example.
No patents were granted between July 2 and August 20, with patent grant volume slowly increasing in September. Grant dates for July 3 to August 19, 2024 appearing in the CIPO database are in error, and are being corrected. This may affect those considering Patent Register listing or applying for Certificates of Supplementary Protection. No Notices of Allowance have been issued for over three months (since July 17), with the Patent Office indicating resumption is “in progress”, with no projected date. Access to many of MyCIPO Patents functionalities are also “in progress”.
IP Horizons, a downloadable databank of trademark, industrial design and patent applications filed with CIPO, remains offline.
For more information on the project, and its current status, please visit MyCIPO Patents – What to Expect.
The preceding is intended as a timely update on Canadian intellectual property and technology law. The content is informational only and does not constitute legal or professional advice. To obtain such advice, please communicate with our offices directly.
Related Publications & Articles
-
Supreme Court of Canada: methods of medical treatment unpatentable, validity of Janssen’s paliperidone dosing regimen patent upheld
Today the Supreme Court of Canada released its decision in Pharmascience Inc v Janssen Inc, 2026 SCC 26 on the patentability of methods of medical treatment, dismissing Pharmascience’s appeal.Read More -
New USPTO rules will affect Canadian innovators not represented by a patent attorney or patent agent
Foreign filing licenses are a common but often overlooked requirement that can create headaches for patent applicants. Failure to obtain the appropriate authorization can lead to consequences ranging ...Read More -
Government of Canada launches consultation on expanding the geographical indications regime
On May 28, 2026, the Government of Canada launched a public consultation on the scope of the geographical indications (GIs) regime under the Trademarks Act. The consultation seeks stakeholders' views ...Read More
